Supplementary data for “Comparisons of Staphylococcus aureus infection and other outcomes between users of angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers: lessons for COVID-19 from a nationwide cohort study”

Laurie Tomlinson ORCID logo; Masao Iwagami; Patrick Bidulka ORCID logo; Yun Sum Wong ORCID logo; (2020) Supplementary data for “Comparisons of Staphylococcus aureus infection and other outcomes between users of angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers: lessons for COVID-19 from a nationwide cohort study”. London School of Hygiene & Tropical Medicine. DOI: 10.17037/PUBS.04656578 (Unpublished)
Copy

Additional information regarding study design, baseline cohort characteristics, and results of sensitivity analyses.


picture_as_pdf
Tomlinson-etal-2020_Supplementary_data_for_Comparisons_of_Staphylococcus.pdf
subject
Supplemental Material
Available under Creative Commons: 3.0

View Download

Atom BibTeX OpenURL ContextObject in Span Multiline CSV OpenURL ContextObject Dublin Core Dublin Core MPEG-21 DIDL EndNote HTML Citation JSON MARC (ASCII) MARC (ISO 2709) METS MODS RDF+N3 RDF+N-Triples RDF+XML RIOXX2 XML Reference Manager Refer Simple Metadata ASCII Citation EP3 XML
Export

Downloads